tiprankstipranks
Trending News
More News >

Sichuan Kelun-Biotech Announces 2025 AGM Agenda

Story Highlights
Sichuan Kelun-Biotech Announces 2025 AGM Agenda

Confident Investing Starts Here:

The latest announcement is out from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H ( (HK:6990) ).

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced its upcoming annual general meeting scheduled for June 20, 2025. Key agenda items include the approval of financial and annual reports for 2024, re-appointment of auditors, remuneration plans for directors and supervisors, and the election of new non-executive and independent non-executive directors for the board. The meeting will also address the acquisition of wealth management products and amendments to procedural rules, indicating strategic planning and governance focus.

The most recent analyst rating on (HK:6990) stock is a Buy with a HK$219.74 price target. To see the full list of analyst forecasts on Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H stock, see the HK:6990 Stock Forecast page.

More about Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a biopharmaceutical company based in China, focusing on the development and commercialization of innovative drugs and therapies. The company operates within the pharmaceutical industry, providing a range of biopharmaceutical products and services.

Average Trading Volume: 701,173

Technical Sentiment Signal: Buy

Current Market Cap: HK$75.23B

For a thorough assessment of 6990 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App